Creative Planning Purchases 20,546 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Creative Planning lifted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 116.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 38,149 shares of the company’s stock after buying an additional 20,546 shares during the period. Creative Planning’s holdings in Option Care Health were worth $1,194,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. increased its holdings in shares of Option Care Health by 317.9% in the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after purchasing an additional 73,312 shares in the last quarter. Comerica Bank increased its stake in Option Care Health by 6.5% in the 1st quarter. Comerica Bank now owns 760,915 shares of the company’s stock valued at $25,521,000 after buying an additional 46,639 shares during the last quarter. Janus Henderson Group PLC increased its stake in shares of Option Care Health by 182.9% during the 1st quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after purchasing an additional 146,837 shares during the last quarter. Edgestream Partners L.P. increased its stake in shares of Option Care Health by 96.8% during the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after purchasing an additional 172,845 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in Option Care Health in the 2nd quarter valued at about $973,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 2.2 %

Shares of NASDAQ OPCH opened at $23.04 on Friday. The firm has a market cap of $3.94 billion, a PE ratio of 19.36, a P/E/G ratio of 2.31 and a beta of 1.29. Option Care Health, Inc. has a 12-month low of $22.84 and a 12-month high of $34.63. The company’s fifty day simple moving average is $30.65 and its 200 day simple moving average is $29.97. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.22 billion. As a group, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In related news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of recent research reports. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a report on Thursday. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $43.00 to $29.00 in a research note on Wednesday. JMP Securities increased their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Finally, Barrington Research decreased their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.